• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨磺必利与氯氮平联合用于难治性精神分裂症患者。

Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.

作者信息

Cook Brian, Hoogenboom Gerry

机构信息

Bundaberg Integrated Mental Health Service, Bundaberg, Queensland 4670, Australia.

出版信息

Australas Psychiatry. 2004 Mar;12(1):74-6. doi: 10.1046/j.1039-8562.2003.02064.x.

DOI:10.1046/j.1039-8562.2003.02064.x
PMID:15715745
Abstract

OBJECTIVE

To report on a trial of adding amisulpride to clozapine.

METHODS

Description of six cases.

RESULTS

Six patients who had been on clozapine were commenced on amisulpride. All patients had had unwanted effects with clozapine, particularly sedation, hypersalivation, or weight gain. Five patients reported a high level of satisfaction with the regimen, having a reduction in the level of sedation and improvement in levels of motivation and energy, without recurrence of positive symptoms.

CONCLUSION

The combined use of amisulpride and clozapine would appear to be an appropriate and beneficial treatment.

摘要

目的

报告一项关于在氯氮平基础上加用氨磺必利的试验。

方法

描述6例病例。

结果

6例服用氯氮平的患者开始加用氨磺必利。所有患者服用氯氮平均出现了不良反应,尤其是镇静、唾液分泌过多或体重增加。5例患者对该治疗方案表示高度满意,镇静程度减轻,动力和精力水平有所改善,且阳性症状未复发。

结论

氨磺必利与氯氮平联合使用似乎是一种合适且有益的治疗方法。

相似文献

1
Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.氨磺必利与氯氮平联合用于难治性精神分裂症患者。
Australas Psychiatry. 2004 Mar;12(1):74-6. doi: 10.1046/j.1039-8562.2003.02064.x.
2
Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.氯氮平与氨磺必利联合治疗难治性精神分裂症——病例报告及文献综述
Pharmacopsychiatry. 2004 Jan;37(1):26-31. doi: 10.1055/s-2004-815471.
3
Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.氯氮平与氨磺必利联合使用减少副作用:病例报告及氯氮平引起流涎过多的简短综述——病例报告
Pharmacopsychiatry. 2005 Jan;38(1):38-9. doi: 10.1055/s-2005-837771.
4
Management of treatment resistant schizophrenia unresponsive to clozapine.对氯氮平无反应的难治性精神分裂症的管理。
Br J Psychiatry Suppl. 1996 Dec(31):31-40.
5
Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.齐拉西酮与氯氮平联合治疗难治性精神分裂症
Hum Psychopharmacol. 2004 Jun;19(4):271-3. doi: 10.1002/hup.580.
6
Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.氨磺必利对氯氮平部分反应或无反应的精神分裂症患者的增效作用。一项随机、双盲、安慰剂对照试验。
Pharmacopsychiatry. 2008 Jan;41(1):24-8. doi: 10.1055/s-2007-993209.
7
Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.通过治疗药物监测优化精神分裂症患者的氨磺必利治疗
J Psychiatr Res. 2007 Oct;41(8):673-9. doi: 10.1016/j.jpsychires.2005.10.003. Epub 2005 Dec 1.
8
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.氨磺必利增强氯氮平疗效:一项针对对氯氮平部分反应的精神分裂症患者的开放性非随机研究。
Acta Psychiatr Scand. 2004 Oct;110(4):292-8. doi: 10.1111/j.1600-0447.2004.00356.x.
9
The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.氨磺必利对精神分裂症患者精神病理学五个维度的影响:一项前瞻性开放标签研究。
BMC Psychiatry. 2005 May 3;5:22. doi: 10.1186/1471-244X-5-22.
10
Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.精神分裂症或分裂情感性障碍不同年龄组患者的氨磺必利剂量与血浆水平
J Psychopharmacol. 2009 May;23(3):278-86. doi: 10.1177/0269881108089806. Epub 2008 Jun 18.

引用本文的文献

1
Update on the management of symptoms in schizophrenia: focus on amisulpride.精神分裂症症状管理的最新进展:重点关注氨磺必利。
Neuropsychiatr Dis Treat. 2009;5:267-77. doi: 10.2147/ndt.s3949. Epub 2009 May 20.
2
Practical issues with amisulpride in the management of patients with schizophrenia.氨磺必利治疗精神分裂症患者时的实际问题
Clin Drug Investig. 2008;28(8):465-77. doi: 10.2165/00044011-200828080-00001.
3
Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.抗精神病药物联合使用的益处与风险:基于证据的文献综述
Drug Saf. 2008;31(1):7-20. doi: 10.2165/00002018-200831010-00002.